NTAQ1
Basic information
Region (hg38): 8:123416726-123470028
Previous symbols: [ "C8orf32", "WDYHV1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NTAQ1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 8 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 8 | 0 | 0 |
Variants in NTAQ1
This is a list of pathogenic ClinVar variants found in the NTAQ1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-123416895-C-G | not specified | Uncertain significance (Nov 27, 2024) | ||
8-123427974-A-G | not specified | Uncertain significance (Jan 23, 2023) | ||
8-123428022-T-C | not specified | Uncertain significance (Nov 15, 2024) | ||
8-123436592-A-G | not specified | Uncertain significance (Jul 26, 2022) | ||
8-123437271-A-G | not specified | Uncertain significance (Dec 28, 2022) | ||
8-123437300-G-C | not specified | Uncertain significance (Dec 06, 2023) | ||
8-123441312-A-G | not specified | Uncertain significance (Jun 18, 2021) | ||
8-123441345-C-T | not specified | Uncertain significance (Dec 11, 2023) | ||
8-123441365-G-A | not specified | Uncertain significance (Nov 21, 2024) | ||
8-123441380-G-A | not specified | Uncertain significance (Apr 19, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NTAQ1 | protein_coding | protein_coding | ENST00000287387 | 6 | 50506 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000824 | 0.533 | 125721 | 0 | 26 | 125747 | 0.000103 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.343 | 99 | 109 | 0.908 | 0.00000551 | 1357 |
Missense in Polyphen | 35 | 43.22 | 0.80982 | 558 | ||
Synonymous | -0.215 | 42 | 40.3 | 1.04 | 0.00000233 | 348 |
Loss of Function | 0.712 | 9 | 11.6 | 0.775 | 5.77e-7 | 140 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000153 | 0.000153 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000168 | 0.000167 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000328 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Mediates the side-chain deamidation of N-terminal glutamine residues to glutamate, an important step in N-end rule pathway of protein degradation. Conversion of the resulting N- terminal glutamine to glutamate renders the protein susceptible to arginylation, polyubiquitination and degradation as specified by the N-end rule. Does not act on substrates with internal or C- terminal glutamine and does not act on non-glutamine residues in any position. Does not deaminate acetylated N-terminal glutamine. With the exception of proline, all tested second-position residues on substrate peptides do not greatly influence the activity. In contrast, a proline at position 2, virtually abolishes deamidation of N-terminal glutamine. {ECO:0000250|UniProtKB:Q80WB5}.;
Recessive Scores
- pRec
- 0.133
Intolerance Scores
- loftool
- 0.756
- rvis_EVS
- 0.86
- rvis_percentile_EVS
- 88.62
Haploinsufficiency Scores
- pHI
- 0.0435
- hipred
- N
- hipred_score
- 0.219
- ghis
- 0.404
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.871
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Wdyhv1
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- cellular protein modification process
- Cellular component
- nucleus;cytosol
- Molecular function
- protein binding;protein-N-terminal asparagine amidohydrolase activity;protein-N-terminal glutamine amidohydrolase activity